Precigen (PGEN) Shares Issued (2012 - 2026)
Precigen (PGEN) reported Shares Issued of $255000.0 for Q1 2026, up 171.83% year-over-year from $93808.3 in Q1 2025, and up 82.14% quarter-over-quarter from $140000.0 in Q4 2025.
Precigen (PGEN) Shares Issued (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Shares Issued data on file, last reported at $255000.0 in Q1 2026.
- Shares Issued for Q1 2026 came in at $255000.0, up 171.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 94.13% YoY), and the FY2025 annual result was $1.2 million, down 96.15% from the prior year.
- Shares Issued climbed to $255000.0 in Q1 2026 per PGEN's latest filing, from $140000.0 in the prior quarter.
- Over five years, Shares Issued peaked at $73.5 million in Q1 2023 and troughed at -$73.5 million in Q2 2023.
- A 4-year average of $10.6 million and a median of $274500.0 in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2025: Shares Issued slumped 99.6% in 2024, then surged 381.97% in 2025.
- A 4-year view of Shares Issued shows it stood at $72.8 million in 2023, then tumbled by 57.57% to $30.9 million in 2024, then slumped by 99.55% to $140000.0 in 2025, then surged by 82.14% to $255000.0 in 2026.
- Business Quant data shows PGEN's Shares Issued at $255000.0 in Q1 2026, $140000.0 in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 26,927.15 |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 255,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 255,000.00 |
| Mar 31, 2026 | 255,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | -355,000.00 |
| Mar 31, 2025 | -355,000.00 |
| Dec 31, 2024 | 30.89 Mn |
| Dec 31, 2024 | 30.89 Mn |
| Sep 30, 2024 | 294,000.00 |
| Sep 30, 2024 | 294,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Jun 30, 2024 | 52,000.00 |
| Sep 30, 2023 | 72.81 Mn |
| Sep 30, 2023 | 72.81 Mn |
| Jun 30, 2023 | -73.50 Mn |
| Jun 30, 2023 | -73.50 Mn |
| Mar 31, 2023 | 73.50 Mn |
| Mar 31, 2023 | 73.50 Mn |